Antabio raised €25m in Series B led by AMR Action Fund, joined by the EIC Fund, BNP Paribas, Relyens Innovation Santé/Turenne Capital, IRDI

Biotech Health services

Investments

03 December 2023

Antabio (company)

Biotech Health services

Total investments received (USD): 27.02m

Round value (USD): 27.02m

Round investors: BNP Paribas EIC Fund IRDI Capital Investissement Relyens Group AMR Action Fund Christophe Ricard

Company: Antabio

Industry: Biotech Health services

AI (big data) Biotech Health services Pharma

Investments 16 January 2024

Biotech Health services Manufacturing Pharma

Investments 24 December 2023

Biotech Health services

Investments 02 December 2023

Biotech Health services Pharma

Investments 12 September 2023